GEN three-lens brief
Evidence-based stock research on GEN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
GEN moved +0.87% overnight.
- Debt-to-equity of 316% — balance-sheet-heavy.
- Earnings scheduled 2026-08-06.
GEN closed at $26.21 (+0.87%) as of 2026-07-10. Market cap: $15.79B. P/E (trailing) 16.7. Price is above the 50-day MA and above the 200-day MA. Concerns: debt-to-equity of 316% — balance-sheet-heavy.. Last quarter: Revenue $1.28B, net income $512.00M, free cash flow $1.42B. Watching for: 2026-08-06 earnings release (26 days out).
Why three lenses on GEN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine GENacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/GEN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath GEN brief"></iframe>